140 related articles for article (PubMed ID: 22251200)
1. Hepatic manifestations of tuberous sclerosis complex: a genotypic and phenotypic analysis.
Black ME; Hedgire SS; Camposano S; Paul E; Harisinghani M; Thiele EA
Clin Genet; 2012 Dec; 82(6):552-7. PubMed ID: 22251200
[TBL] [Abstract][Full Text] [Related]
2. Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors.
Rakowski SK; Winterkorn EB; Paul E; Steele DJ; Halpern EF; Thiele EA
Kidney Int; 2006 Nov; 70(10):1777-82. PubMed ID: 17003820
[TBL] [Abstract][Full Text] [Related]
3. Tuberous sclerosis complex: genotype/phenotype correlation of retinal findings.
Aronow ME; Nakagawa JA; Gupta A; Traboulsi EI; Singh AD
Ophthalmology; 2012 Sep; 119(9):1917-23. PubMed ID: 22608477
[TBL] [Abstract][Full Text] [Related]
4. The analysis of mutations and exon deletions at TSC2 gene in angiomyolipomas associated with tuberous sclerosis complex.
Yang HM; Choi HJ; Hong DP; Joo SY; Lee NE; Song JY; Choi YL; Lee J; Choi D; Kim B; Park HJ; Park JB; Kim SJ
Exp Mol Pathol; 2014 Dec; 97(3):440-4. PubMed ID: 25281918
[TBL] [Abstract][Full Text] [Related]
5. Liver Angiomyolipomas in Tuberous Sclerosis Complex-Their Incidence and Course.
Jóźwiak S; Sadowski K; Borkowska J; Domańska-Pakieła D; Chmielewski D; Jurkiewicz E; Jaworski M; Urbańska M; Ogrodnik M; Słowińska M; Kotulska K
Pediatr Neurol; 2018 Jan; 78():20-26. PubMed ID: 29249553
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Tuberous Sclerosis Complex Associated With Renal Lesions by Targeted Next-generation Sequencing in Mainland China.
Cai Y; Li H; Zhang Y
Urology; 2017 Mar; 101():170.e1-170.e7. PubMed ID: 28065512
[TBL] [Abstract][Full Text] [Related]
7. Genotype-phenotype correlation of patients with tuberous sclerosis complex-associated renal angiomyolipoma: a descriptive study.
Li S; Zhang Y; Wang Z; Yang Y; Gao W; Li D; Wei J
Hum Pathol; 2018 Dec; 82():61-67. PubMed ID: 30036593
[TBL] [Abstract][Full Text] [Related]
8. Deep phenotyping of patients with Tuberous Sclerosis Complex and no mutation identified in TSC1 and TSC2.
Peron A; Vignoli A; Briola F; Morenghi E; Tansini L; Alfano RM; Bulfamante G; Terraneo S; Ghelma F; Banderali G; Viskochil DH; Carey JC; Canevini MP;
Eur J Med Genet; 2018 Jul; 61(7):403-410. PubMed ID: 29432982
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of thoracoabdominal imaging findings in tuberous sclerosis complex.
Ritter DM; Fessler BK; Ebrahimi-Fakhari D; Wei J; Franz DN; Krueger DA; Trout AT; Towbin AJ
Orphanet J Rare Dis; 2022 Mar; 17(1):124. PubMed ID: 35292049
[TBL] [Abstract][Full Text] [Related]
10. Tuberous sclerosis complex: clinical features, diagnosis, and prevalence within Northern Ireland.
Devlin LA; Shepherd CH; Crawford H; Morrison PJ
Dev Med Child Neurol; 2006 Jun; 48(6):495-9. PubMed ID: 16700943
[TBL] [Abstract][Full Text] [Related]
11. Severity of manifestations in tuberous sclerosis complex in relation to genotype.
Kothare SV; Singh K; Chalifoux JR; Staley BA; Weiner HL; Menzer K; Devinsky O
Epilepsia; 2014 Jul; 55(7):1025-9. PubMed ID: 24917535
[TBL] [Abstract][Full Text] [Related]
12. Renal involvement in tuberous sclerosis complex with emphasis on cystic lesions.
Robert A; Leroy V; Riquet A; Gogneaux L; Boutry N; Avni FE
Radiol Med; 2016 May; 121(5):402-8. PubMed ID: 26219723
[TBL] [Abstract][Full Text] [Related]
13. Systemic disease manifestations associated with epilepsy in tuberous sclerosis complex.
Jeong A; Wong M
Epilepsia; 2016 Sep; 57(9):1443-9. PubMed ID: 27417921
[TBL] [Abstract][Full Text] [Related]
14. Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2.
Kwiatkowski DJ; Palmer MR; Jozwiak S; Bissler J; Franz D; Segal S; Chen D; Sampson JR
Eur J Hum Genet; 2015 Dec; 23(12):1665-72. PubMed ID: 25782670
[TBL] [Abstract][Full Text] [Related]
15. Cyst-like tubers are associated with TSC2 and epilepsy in tuberous sclerosis complex.
Chu-Shore CJ; Major P; Montenegro M; Thiele E
Neurology; 2009 Mar; 72(13):1165-9. PubMed ID: 19332694
[TBL] [Abstract][Full Text] [Related]
16. Renal manifestations of tuberous sclerosis complex: patients' and parents' knowledge and routines for renal follow-up - a questionnaire study.
Cockerell I; Guenin M; Heimdal K; Bjørnvold M; Selmer KK; Rouvière O
BMC Nephrol; 2018 Feb; 19(1):39. PubMed ID: 29439672
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype--phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex.
Sancak O; Nellist M; Goedbloed M; Elfferich P; Wouters C; Maat-Kievit A; Zonnenberg B; Verhoef S; Halley D; van den Ouweland A
Eur J Hum Genet; 2005 Jun; 13(6):731-41. PubMed ID: 15798777
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic neuroendocrine tumors in patients with tuberous sclerosis complex.
Larson AM; Hedgire SS; Deshpande V; Stemmer-Rachamimov AO; Harisinghani MG; Ferrone CR; Shah U; Thiele EA
Clin Genet; 2012 Dec; 82(6):558-63. PubMed ID: 22035404
[TBL] [Abstract][Full Text] [Related]
19. Low-level mosaicism in tuberous sclerosis complex: prevalence, clinical features, and risk of disease transmission.
Giannikou K; Lasseter KD; Grevelink JM; Tyburczy ME; Dies KA; Zhu Z; Hamieh L; Wollison BM; Thorner AR; Ruoss SJ; Thiele EA; Sahin M; Kwiatkowski DJ
Genet Med; 2019 Nov; 21(11):2639-2643. PubMed ID: 31160751
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of the tuberous sclerosis complex at patients taken care for a renal angiomyolipoma].
Maulaz P; Malinge MC; Farges D; Ingster O; Azzouzi AR; Bigot P
Prog Urol; 2020 Sep; 30(10):500-506. PubMed ID: 32718886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
